Angelini Ventures is the corporate venture capital arm of Angelini Industries, based in Rome and focused on digital health, biotech and broader life sciences. It invests in health companies developing integrated healthcare platforms and technologies that improve care models and human health. The firm backs seed, early-stage and later-stage venture rounds across Europe and the United States, including biotechnology, pharmaceuticals, oncology and women’s health, and has acted as a co-lead investor in Series A and Series B financings. Angelini Ventures has €300 million of investment capital and has invested €100 million.